Key clinical point before the protocol

• Was the cut nerve repaired at the time of surgery (primary end-to-end suture, cable graft e.g. sural/great auricular nerve, or a nerve substitution procedure)? If yes, regenerating axons grow at ~1 mm/day, so return of tone can take 6-18 months depending on graft length — at 1.5 years you may be at the point where early reinnervation/synkinesis is just starting to appear, or has plateaued.
• If the nerve was cut and never repaired, physiotherapy alone cannot restore voluntary movement because there are no axons to retrain — this becomes a facial reanimation surgery question (nerve grafting is usually only viable within ~12-24 months of denervation before the mimetic muscles atrophy irreversibly; beyond that, options shift to muscle transfer, e.g. temporalis transfer or free gracilis flap). At 1.5 years post-injury with zero movement, this needs an urgent referral/re-discussion with a facial nerve/plastics surgeon if it hasn't happened already, in parallel with physiotherapy.

1. Assessment first

• Grade with Sunnybrook Facial Grading System or House-Brackmann scale to have a baseline and track progress objectively.
• Corneal/eye assessment is priority given incomplete eye closure (lagophthalmos) — check for exposure keratopathy, Bell's phenomenon, tear film status.

2. Eye protection (highest priority — prevents corneal damage)

• Lubricating eye drops during the day, thicker ointment + eye taping/moisture chamber at night.
• If closure remains poor, refer to oculoplastics for adjuncts (upper eyelid weight, lateral tarsorrhaphy, or botulinum-toxin induced ptosis) — this is standard multidisciplinary facial-nerve-clinic practice - Scott-Brown's Otorhinolaryngology Head & Neck Surgery, Vol 2, p. 1451.

3. Neuromuscular retraining (core evidence-based technique)

• Mirror-based, small-amplitude, high-repetition movements performed slowly with conscious control, progressing from isolated muscle activation to functional patterns like smiling and eye closure, with the goal of symmetric, coordinated movement rather than maximal effort (which promotes synkinesis).
• A 2024 systematic review and meta-analysis of 7 RCTs (418 patients) found physical therapy reduced non-recovery (RR 0.51, 95% CI 0.31-0.83) and improved Sunnybrook composite scores (MD +12.1), though certainty of evidence was rated low/very low (Nakano et al., Auris Nasus Larynx, 2024, PMID 37149416).
• A 2025 systematic review of 12 studies (228 patients) also concluded physical therapy consistently improved facial rehabilitation outcomes and should be part of standard management (Varelas et al., Am J Otolaryngol, 2025, PMID 39647183).
• Proprioceptive neuromuscular facilitation (PNF) has specific supporting evidence for improving symmetry and function in facial paralysis (Silva et al., Braz J Phys Ther, 2022).

4. Soft tissue and manual techniques

• Gentle facial massage, myofascial release, and stretching of the unaffected/overactive side to reduce compensatory pull and improve symmetry.
• Thermal modalities (warm compress) before exercise to improve tissue extensibility.

5. Electrical stimulation — use with caution

• Evidence is mixed. Non-selective/high-intensity e-stim in flaccid palsy is generally discouraged because it can promote mass movement patterns and synkinesis once reinnervation occurs.
• Newer, more targeted approaches (e.g., functional electrical stimulation of specific muscles like zygomaticus or orbicularis oculi) show promise in recent studies but are not yet standard of care — treat as adjunct, not primary therapy.

6. Home program and biofeedback

• Daily home mirror exercises (5-10 minutes, several times/day) plus self-massage — home programs combined with clinic sessions are consistently part of protocols with >90% patient-reported benefit in traumatic facial palsy case series - K J Lee's Essential Otolaryngology, p. 1053.
• EMG or visual biofeedback can help patients avoid overflow/synkinetic movements.

7. Multidisciplinary referral (important at 1.5 years chronicity)

8. Psychological/quality-of-life support

Bottom line for your patient

Bottom line first

Why timing is the dominant variable in the literature

• Early repair clearly outperforms delayed repair. In a study specifically on hypoglossal-facial nerve grafting after operative facial nerve injury, patients repaired acutely (0-14 days) were nearly 5 times more likely to reach House-Brackmann grade ≤3 than those repaired later (OR 4.97, 95% CI 1.5-16.9, p=0.01) - Yawn et al., cited via Ento Key review.
• A 60-day to 6-month "practical ceiling" is commonly cited for direct nerve grafting: as delay increases, myelinated fiber regrowth across the graft/anastomosis drops progressively, and some groups recommend repair should not exceed ~60 days when direct grafting is planned - Jeong et al., Microsurgery, PMC11098761, 2024.
• Beyond 1-2 years, direct nerve repair/graft outcomes decline further, but nerve-transfer options (not dependent on the old distal nerve trunk) can still work if the target muscle is still viable. Manni et al. (cited in the same review) reported successful hypoglossal-facial reanimation even in patients with more than 2 years of paralysis, though the longer the paralysis duration, the slower and less complete the recovery (HB III achieved in 44% overall, but HB II recovery only occurred in the early-surgery group).
• The rate-limiting biology: distal Wallerian degeneration progresses and motor endplates in the denervated muscle degenerate over time - beyond roughly 18-24 months of complete denervation, muscle fibrosis and endplate loss become the limiting factor rather than nerve regrowth capacity itself - Cummings Otolaryngology Head and Neck Surgery, NERVE REPAIR section, p. 3321.

Current evidence-based technique options (2021-2025 literature)

• Masseteric-to-facial nerve transfer (V-VII transfer): now often preferred over hypoglossal-facial transfer because it avoids tongue morbidity/atrophy, gives strong, relatively fast reinnervation, and can be combined with a fascia lata interposition graft for extra reach - Zhou et al., Plast Reconstr Surg, 2025 (PMID 40434662).
• Hypoglossal-facial nerve transfer/anastomosis (XII-VII), often with a jump graft (great auricular or sural nerve) to preserve tongue function - still a well-established option, particularly for proximal/skull-base injuries - Hayashi, No Shinkei Geka, 2022 (PMID 35670182).
• Cross-facial nerve grafting (CFNG): harvests branches from the healthy contralateral facial nerve to drive the paralyzed side, aiming for a spontaneous/emotional smile rather than just volitional movement; newer intra-oral vascularized CFNG techniques have been reported for early flaccid palsy - Kannan et al., Microsurgery, 2025 (PMID 41287219).
• Dual or triple nerve transfer (current trend): combining masseteric nerve transfer (for reliable strength/tone) with a cross-facial nerve graft (for spontaneity) is increasingly the preferred strategy in recent series, giving both a strong voluntary bite-triggered smile and potential for involuntary smile as the CFNG matures - Okland & Pepper, Facial Plast Surg Clin North Am, 2021 (PMID 34217442); Kollar et al., Plast Reconstr Surg, 2024 (PMID 37384874); Telich-Tarriba et al. (triple transfer), 2023 (PMID 37554097).

• Free functional muscle transfer, most commonly a gracilis muscle flap re-innervated by the masseteric nerve (single-stage) or by a cross-facial nerve graft placed 6-9 months earlier (two-stage "cross-facial nerve graft + gracilis" approach) - this is the standard of care once native muscle is no longer salvageable - UNC Facial Nerve Center protocol; Iowa Protocols on cross-face nerve grafting.
• Static procedures (fascia lata sling, lower eyelid weight, tarsorrhaphy) remain adjuncts for symmetry and eye protection regardless of which dynamic procedure is chosen.

What I'd recommend concretely for your patient

1. Get an EMG/electroneurography of the facial mimetic muscles now - this is the deciding test at 18 months. Fibrillation potentials or motor unit activity means the muscle is still reinnervatable (nerve transfer route); electrical silence means fibrosis has set in (free muscle transfer route).
2. Refer urgently to a facial nerve reanimation surgeon (plastic surgery/otolaryngology with facial nerve subspecialty) - do not wait longer, since every additional month reduces the probability that a nerve-transfer option (versus needing free muscle transfer later) will work.
3. Continue physiotherapy in parallel (eye protection, neuromuscular retraining, soft tissue work as already outlined) - this does not delay or conflict with surgical planning and helps optimize the tissue bed and patient function while awaiting surgery.
4. Eye care remains urgent regardless of surgical pathway - if incomplete closure persists, consider an eyelid weight or tarsorrhaphy now rather than waiting for the dynamic reanimation to mature (which can take 6-12+ months even after successful nerve transfer).

Stage classification

Core principles for this stage

1. Small, slow, isolated movements only — never maximal effort. Mass, effortful movements at this stage are the main driver of synkinesis because early regenerating axons are prone to aberrant/misdirected reinnervation.
2. Quality over quantity — 10-15 minutes, several short sessions/day, rather than long fatiguing sessions.
3. Mirror + EMG/visual biofeedback guided — patient must watch the muscle contract, not just feel for movement.

Protocol

• Warm compress 5 min to improve tissue extensibility.
• Gentle self-massage/soft tissue mobilization of the paretic muscles (effleurage, light kneading) to reduce stiffness and improve circulation before facilitation work.

• Frequency: 2-4 Hz (low-frequency, trophic — not tetanic/strengthening parameters)
• Pulse duration ~100 ms, interval ~300 ms
• Intensity: comfortable, just enough to produce a visible small contraction — never painful, never maximal
• Daily, for at least 3 consecutive weeks before reassessing
• Purpose: improve compound muscle action potential (CMAP), circulation, and pain threshold — evidence shows benefit in facial movement quality and reduced synkinesis when used early with these specific submaximal parameters. High-intensity/tetanic stimulation is avoided deliberately because it promotes mass co-contraction and synkinesis.

• Work at three fulcrums: superior (frontalis/orbicularis oculi), intermediate (nasal/zygomatic/cheek), inferior (orbicularis oris/lip depressors) — facial fibers run diagonally, so facilitation follows these diagonal lines rather than straight up-down stretching.
• Technique: therapist applies a light quick-stretch plus manual resistance cue in the direction of the muscle fiber, asking the patient to actively complete a small, slow contraction against this cue.
• Daily sessions, minimum 3 weeks before reassessing for change.
• Combine with active-assisted movement: therapist/patient's own finger gives light tactile cueing at the target muscle while the patient attempts the movement, reinforcing the correct isolated pattern rather than a global "try hard" effort.

• Practice isolated small-amplitude movements one muscle group at a time (e.g., just a subtle corner-of-mouth lift, not a full smile yet) in front of a mirror.
• Sequence: start with the muscle showing contraction on EMG, master a slow controlled 2-3 second hold + release, then progress to combining with adjacent muscles only once each is independently controlled.
• Avoid attempting global expressions (full smile, big blink) until isolated control is reliable — this is the key anti-synkinesis rule from current facial rehab practice.

• Breathing and relaxation exercises to reduce compensatory overactivity of the unaffected/normal side.
• Bilateral symmetry exercises — training both sides together so the brain relearns coordinated, not one-sided, activation.
• Functional targets once isolated control improves: gentle lip closure/pursing for eye and lip closure, cheek puffing, gentle "ee/oo" sounds — functional, low-load movements before resistance work.
• Kinesiotaping can be used to provide proprioceptive feedback and mechanically support symmetry between sessions.

• Do NOT add resistance exercises or high-effort exercises until the patient can perform small isolated movements smoothly without any visible co-contraction elsewhere on the face.
• Re-grade with Sunnybrook Facial Grading System every 4-6 weeks; use this, not just "more movement," to decide when to progress intensity.
• If early synkinesis appears (unwanted co-contraction, e.g., eye narrowing when trying to smile), that specific pattern should be addressed early with targeted PNF/inhibition techniques, and a low-dose chemodenervation (botulinum toxin) consult can be considered as an adjunct to physiotherapy for the overactive/synkinetic muscle — this combination (NMR + preceding low-dose BoNT-A) has shown good results even in chronic partial-recovery facial palsy in recent clinical series (Jeong et al., Acta Otolaryngol, 2023).

Research on synkinesis prevention during early facial nerve reinnervation

1. Mechanism papers (why synkinesis happens during reinnervation)

• Rail B, Henn D, Wen YE, et al. "Clinical Perspectives on the Pathophysiology of Facial Synkinesis: A Narrative Review." JAMA Otolaryngology-Head & Neck Surgery, 2025. PMID 39745730. Explains that synkinesis results from aberrant axonal misdirection during regeneration — regrowing facial nerve axons get misrouted into motor endplates of unintended muscle groups, and central cortical reorganization further fixes these faulty patterns if not corrected early.
• Guntinas-Lichius O, Prengel J, Cohen O, et al. "Pathogenesis, diagnosis and therapy of facial synkinesis: A systematic review and clinical practice recommendations by the international head and neck scientific group." Frontiers in Neurology, 2022. PMID 36438936. This is the most heavily cited synkinesis paper in the field — provides consensus clinical practice recommendations, and explicitly recommends starting neuromuscular retraining early, before synkinesis is established, as the primary prevention strategy.

2. Direct evidence on early neuromuscular retraining (NMRT) as prevention

• Kim DR, Kim JH, Jung SH, et al. "Neuromuscular retraining therapy for early stage severe Bell's palsy patients minimizes facial synkinesis." Clinical Rehabilitation, 2023;37(11):1510-1520. Directly relevant to your patient's stage — shows that starting NMR therapy early in severe palsy (before synkinesis develops) measurably reduces the eventual degree of synkinesis compared with delayed/no retraining.
• Kim J. "Prevention and Treatment of Post-Paralytic Synkinesis: Critical Changes Following Severe Facial Palsy." J Electrodiagn Neuromuscul Dis, 2024;26(2):19-24. Practical review specifically on prevention: recommends early patient education about likely synkinesis patterns (oral-ocular, chin-oral, nasal-oral, platysmal) before they appear, typically emerging around 5-6 months after onset, and teaches patients to consciously suppress excessive/co-contracted movements from the first signs of reinnervation — this pre-emptive awareness training is described as a "crucial component" of early NMRT.
• Silva MC, Oliveira MT, Azevedo-Santos IF, DeSantana JM. "Effect of proprioceptive neuromuscular facilitation in the treatment of dysfunctions in facial paralysis: a systematic literature review." Braz J Phys Ther, 2022. PMID 36279766. Systematic review supporting PNF's role specifically in improving recovery of function and reducing synkinesis risk (aligns with the three-fulcrum PNF protocol already outlined for your patient).

3. Adjunctive surgical strategy for prevention

• Di Stadio A, Ralli M, De Luca P, et al. "Combining early lower eyelid surgery with neuromuscular retraining for synkinesis prevention after facial palsy: the role of the eye in aberrant facial nerve regeneration." Frontiers in Neurology, 2024. PMID 39359872. Novel finding: correcting paralytic lagophthalmos/ectropion early (surgically) and combining it with NMR reduced synkinesis development compared to NMR alone — suggests ongoing corneal exposure/eyelid dysfunction itself may feed into aberrant reinnervation patterns around the eye, reinforcing why your patient's eye care must continue in parallel with retraining.

4. Management once synkinesis has already developed (useful if prevention is incomplete)

• de Jongh FW, Schaeffers AWMA, Kooreman ZE, et al. "Botulinum toxin A treatment in facial palsy synkinesis: a systematic review and meta-analysis." Eur Arch Otorhinolaryngol, 2023. PMID 36544062. Confirms BoNT-A as effective adjunct once synkinetic patterns emerge, typically combined with ongoing NMR (not a replacement for it).
• Lapidus JB, Lu JC, Santosa KB, et al. "Too much or too little? A systematic review of postparetic synkinesis treatment." JPRAS, 2020. PMID 31786138. Reviews the balance across physical therapy, botulinum toxin, and nerve blocks for established synkinesis.
• Zubler C, Punreddy A, Mayorga-Young D, et al. "Approaches to the Management of Synkinesis: A Scoping Review." Facial Plastic Surgery, 2024. PMID 38604247. Broad scoping review across all modalities (physiotherapy, chemodenervation, selective neurectomy) — useful as a single reference covering the full management ladder if synkinesis progresses despite prevention efforts.

Practical takeaway for your patient

1. Start structured NMR/PNF immediately (not after synkinesis appears) — confirmed by Kim et al. 2023 (PMID above) to reduce eventual synkinesis severity.
2. Educate the patient now on which synkinetic patterns to watch for (eye narrowing with mouth movement, chin dimpling with eye closure, etc.) so both you and the patient can catch and consciously suppress the earliest signs — this pre-emptive awareness component is specifically highlighted as critical in the Kim 2024 review.